Developer of a private digital healthcare platform designed to democratize the private healthcare market and provide healthcare services. The company's one-stop shop platform offers general medicine, specialist health services, dermatologists, physical therapists, psychologists, and other medical issues covering a wide range of diseases, thereby enabling patients with instant access to care services at an affordable price, both physically and digitally.
PathoQuest SAS is a biotechnology company based in Paris, France, focused on advancing pathogen detection through a metagenomics approach. Founded in 2010 as a spin-off from Institut Pasteur, the company utilizes proprietary next-generation sequencing (NGS) technology to provide actionable reports for clinicians, biologists, and biopharmaceutical professionals. PathoQuest’s offerings include the iDTECTTM Dx Blood test for pathogen identification and a comprehensive database that enhances diagnostic accuracy. Additionally, the company provides Viral Safety testing services specifically designed for biopharmaceutical firms, which has quickly established a revenue stream from major industry players. The integration of advanced sample preparation and cloud-based bioinformatics enables improved detection capabilities across various biological samples, allowing healthcare professionals to address the limitations of traditional infectious agent detection methods.
Incision is a developer of a medical education platform that aims to standardize the process of learning surgical procedures. The platform provides a structured approach, breaking down procedures into practical steps and sub-steps. By facilitating access to shared experiences, skills, and expertise, Incision enables medical students to prepare effectively for their roles in the operating room. This comprehensive preparation is designed to enhance the competencies and skills necessary for success in surgical environments.
Incision is a developer of a medical education platform that aims to standardize the process of learning surgical procedures. The platform provides a structured approach, breaking down procedures into practical steps and sub-steps. By facilitating access to shared experiences, skills, and expertise, Incision enables medical students to prepare effectively for their roles in the operating room. This comprehensive preparation is designed to enhance the competencies and skills necessary for success in surgical environments.
Salvia BioElectronics B.V., founded in 2017 and based in Eindhoven, the Netherlands, specializes in developing bioelectronic therapies for individuals with chronic neurological diseases. The company operates in the burgeoning field of bioelectronics, merging principles of biology and electronics to create innovative therapeutic solutions. The name "Salvia," derived from the Latin word for "to stay healthy," reflects the company's commitment to enhancing health and well-being. Salvia aims to deliver accessible bioelectronic treatments that address severe neurological disorders. The team comprises experienced professionals from diverse backgrounds in the medical device industry, including notable companies such as Medtronic and Philips, ensuring a strong foundation for the development of their cutting-edge technologies.
Neuro Event Labs Oy is a Finnish medical technology company founded in 2015 and based in Tampere. The company specializes in developing artificial intelligence-powered software that monitors epilepsy patients both at home and in clinical settings. Its primary product collects and analyzes accurate data on epilepsy seizures through the use of video and various sensors, leveraging computer vision, smart analytics, and machine learning. This data is relayed to healthcare providers, allowing them to make informed treatment decisions tailored to individual patients. The solution has been crafted in collaboration with leading hospitals in Finland, enhancing its reliability and effectiveness in managing epilepsy care.
Private Equity Round in 2020
Blazejewski MEDI-TECH GmbH develops, manufactures, and distributes private label medical endoscopes and visualization units for minimally invasive and surgical applications. It offers endoscopes with and without working channels, 3D stereoscopy products, rigid endoscopes, angled optics, semi-flexible endoscopes, and OEM electronics. The company serves original equipment manufacturers in Germany and internationally. Blazejewski MEDI-TECH GmbH was founded in 1991 and is based in Emmendingen, Germany.
Selfapy GmbH is a Berlin-based company that provides online therapy programs aimed at individuals experiencing mental health challenges, particularly depression. Founded in 2016, Selfapy offers a range of therapy-related services, including programs focused on anxiety, eating disorders, stress management, and chronic panic. The company utilizes a guided self-help approach, allowing users to engage with exercises, videos, and texts over a three-month period, facilitated through phone or SMS interactions. These programs are designed to help users recognize negative thought patterns and develop healthier behaviors, all while ensuring anonymity and flexibility in the therapeutic process. Selfapy serves as a supportive tool for those seeking to improve their mental well-being.
Single Use Support GmbH, founded in 2015 and based in Kufstein, Austria, specializes in manufacturing heavy-duty single-use plastic containers and packaging products designed for the transportation of liquids, particularly within the pharmaceutical and biopharma sectors. The company develops bulk filling systems, including BULK.STREAM and RoSS.FILL, which facilitate the efficient logistics of liquid handling. By focusing on preventing losses due to leakages and bio-contamination, Single Use Support aims to enhance the logistics processes for its clients, providing tailored packaging solutions that meet specific requirements in the industry.
GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.
Betterguards Technology GmbH, founded in 2011 and based in Berlin, Germany, specializes in innovative protective solutions for joints and ligaments. The company offers adaptors that can be attached to various items such as shoes, gloves, bandages, and orthotic devices, specifically designed to stabilize the ankle, wrist, and knee joints. These products are integrated into work and sports shoes to prevent injuries from twisting or falling, benefiting athletes in sports like football, basketball, skiing, and motocross, as well as individuals with unstable ankles and the elderly who face a higher risk of falls due to balance disorders. Betterguards' technology allows for a full range of motion while effectively protecting against injury-causing movements, much like a seatbelt in a vehicle.
evitria AG engages in the research and development of protein design and expression products. It offers carbon hydrogen oxygen (CHO) based antibodies for protein design, transient gene expression, and stable cell lines. The company also offers a protein expression platform which allows fast production of gram quantities of protein in HEK293 and CHO cells and helps in adeno-associated virus (AAV) and lentivirus-mediated gene transfer. The company was founded in 2010 and is based in Schlieren, Switzerland.
Miracor Medical is a medical device company that specializes in developing solutions for severe cardiac diseases. Founded in 2008 and headquartered in Awans, Belgium, the company focuses on the PiCSO Impulse System, a pressure-controlled intermittent coronary sinus occlusion device. This system is designed to assist cardiac surgeons in treating patients with myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. By improving microvascular perfusion through the coronary sinus, the PiCSO Impulse System aims to reduce infarct size and enhance cardiac function, potentially lowering the risk of heart failure following acute myocardial infarction.
CoreMedic AG develops and manufactures devices and therapies to address the treatment of heart valve diseases. The company offers ChordArt, a mitral valve repair system which focuses on the minimally invasive, trans-femoral repair at the beating heart. It is developing two systems which facilitate delivery and deployment of the implant. Additionally, the company provides ChordArt S, which reduces invasiveness of the surgical procedure by repairing the valve in a way which allows the surgeon to focus on the procedure and timing rather than manually placing the sutures to repair the valve; and ChordArt C which allows for the valve repair to be carried out via the vascular route through a tiny incision in the groin. CoreMedic AG was founded in 2012 and is headquartered in Biel/Bienne, Switzerland.
Medigroba GmbH provides healthcare services. The Company specializes in the care of patients in hospitals, nursing facilities, and at home. Medigroba serves patients in Germany.
Miracor Medical is a medical device company that specializes in developing solutions for severe cardiac diseases. Founded in 2008 and headquartered in Awans, Belgium, the company focuses on the PiCSO Impulse System, a pressure-controlled intermittent coronary sinus occlusion device. This system is designed to assist cardiac surgeons in treating patients with myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. By improving microvascular perfusion through the coronary sinus, the PiCSO Impulse System aims to reduce infarct size and enhance cardiac function, potentially lowering the risk of heart failure following acute myocardial infarction.
Emerging Implant Technologies specializes in the design and manufacture of orthopedic spinal implants, utilizing advanced additive manufacturing methods such as three-dimensional printing. Founded in 2014 and headquartered in Tuttlingen, Germany, the company develops products including cervical cages and PLIF and TLIF cages. These implants are engineered to promote bone growth after fusion surgeries and aim to reduce complication rates, thereby improving patient outcomes. Since September 2018, Emerging Implant Technologies has operated as a subsidiary of Johnson & Johnson Medical, focusing on innovation in the orthopedic implant sector.
Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.
Tyromotion GmbH is a company that manufactures and distributes robotic-assisted and computer-aided therapy units, specializing in rehabilitation technologies that utilize mechatronic systems. Established in 2007 and headquartered in Graz, Austria, with an additional office in New York City, Tyromotion focuses on the development of the Amadeo System. This innovative mechatronic rehabilitation device is designed to aid in the rehabilitation of patients suffering from motor dysfunctions of the distal upper extremity. The company's products aim to enhance therapeutic outcomes through advanced technology in the field of rehabilitation.
Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.
Puracon is a provider of medical packaging and logistics services headquartered in Rosenheim, Germany. Established in 2003, the company specializes in sterile packaging solutions for the medical technology, pharmacology, and biotechnology sectors. Puracon offers a comprehensive range of services, including contract packaging, which encompasses inspection, cleaning, assembly, sterilization, and validation of medical products. Additionally, it provides logistics services such as storage and shipping, as well as consulting services to support product approvals. By focusing on conformity, efficiency, and safety, Puracon assists its clients in navigating the complexities of medical product compliance and distribution. The company operates as a subsidiary of KLINGEL medical metal GmbH.
SIS SCHWAGER Group through its subsidiaries develops, produces, and sells products for the treatment of vascular disease. It began operation in 2005, with its headquarters in Winterthur in Switzerland.
ndd Medizintechnik AG specializes in the manufacture of pulmonary function testing products. The company provides a range of spirometers, including the EasyOne Worldspirometer, a portable testing device, and the EasyOne Pro LAB, which offers comprehensive spirometry, single-breath carbon monoxide diffusion, and multi-breath nitrogen washout capabilities. Other products include the EasyOne Pro, a solution for spirometry and single-breath carbon monoxide diffusion, as well as the EasyOne-Line, which features direct connectivity to a PC, and Easy on-PC, a dedicated PC spirometry solution. Additionally, ndd Medizintechnik supplies various accessories such as disposable spirettes and barriers. Founded in 1992, the company is headquartered in Zurich, Switzerland, and markets its products through dealers both domestically and internationally, as well as online.
Novo Klinik-Service GmbH specializes in the development and production of medical fixations and pads for the intensive care, anesthetic, and nursing sectors, both in Germany and internationally. The company offers a range of products including tracheostomy and laryngectomy fixations and accessories, ventilation fixations and accessories, as well as securement devices and prophylactic solutions. Additionally, it provides innovative solutions such as Novobil One, an ultra-light trolley designed to fit in various elevators, and ITS-Novo, a modular intensive care patient room. Founded in 1987, Novo Klinik-Service is headquartered in Kerpen, Germany.
Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.
GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.
Les Delices des 7 Vallees, founded in 1996 and headquartered in Tincques, France, specializes in the production of frozen cakes and pastries. As a subsidiary of Mademoiselle Desserts SAS, the company manufactures a variety of frozen patisserie products, including desserts and confectionery items. Les Delices des 7 Vallees is committed to blending traditional recipes with modern culinary trends, using carefully selected fresh ingredients to ensure quality and flavor in their offerings.
Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.
Miracor Medical is a medical device company that specializes in developing solutions for severe cardiac diseases. Founded in 2008 and headquartered in Awans, Belgium, the company focuses on the PiCSO Impulse System, a pressure-controlled intermittent coronary sinus occlusion device. This system is designed to assist cardiac surgeons in treating patients with myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. By improving microvascular perfusion through the coronary sinus, the PiCSO Impulse System aims to reduce infarct size and enhance cardiac function, potentially lowering the risk of heart failure following acute myocardial infarction.
Vimecon GmbH develops and produces laser catheter for the treatment of heart diseases with a focus on Atrial Fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. In addition, Vimecon GmbH advises various customers from the scholar and industrial research and development. The company was founded in 2005 and is based in Herzogenrath, Germany.
TRI Dental Implants specializes in the development, design, and manufacturing of advanced dental implant systems. The company offers a diverse range of products, including various implant types, such as soft tissue concepts, friction and bone adaptation systems, as well as sandblasted, large grit, and acid-etched surface implant systems. Their portfolio also features vent implant lines, narrow and octa implants, prosthetic products, and surgical kits tailored for dental professionals. TRI Dental Implants distributes its offerings through a network of partners in numerous countries, including Australia, China, and various European nations, while also allowing direct online orders in specific regions. Founded by Tobias S. Richter in 2010, the company is headquartered in Baar, Switzerland, and emphasizes innovative delivery methods to enhance the efficiency of dental procedures.
Miracor Medical is a medical device company that specializes in developing solutions for severe cardiac diseases. Founded in 2008 and headquartered in Awans, Belgium, the company focuses on the PiCSO Impulse System, a pressure-controlled intermittent coronary sinus occlusion device. This system is designed to assist cardiac surgeons in treating patients with myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. By improving microvascular perfusion through the coronary sinus, the PiCSO Impulse System aims to reduce infarct size and enhance cardiac function, potentially lowering the risk of heart failure following acute myocardial infarction.
numares AG, founded in 2004 and headquartered in Regensburg, Germany, specializes in the development and marketing of software-based test systems for clinical diagnostics and life science research. The company offers an in vitro diagnostic (IVD) system known as AXINON, which utilizes nuclear magnetic resonance (NMR) spectroscopy to analyze metabolomic networks. Through this technology, numares AG provides physicians with valuable insights into patients' disease status. The company employs magnetic group signaling (MGS) technology to enhance its NMR-based diagnostic solutions, focusing on areas such as cardiovascular diseases, nephrology, oncology, and neurology. As a prominent player in commercial NMR analytics in Europe, numares AG is recognized for delivering fast, cost-efficient, and reliable diagnostic services.
Spiegelberg is a medical equipment company based in Hamburg, Germany, established in 1986. The company specializes in the development, production, and sale of devices for neurosurgical applications, including intracranial pressure monitors, probes, catheters, and external ventricular drain kits. Additionally, Spiegelberg offers antimicrobial products designed to prevent hospital-acquired infections. By focusing on safety in diagnosis and minimally invasive treatments, Spiegelberg aims to enhance patient health outcomes.
Phenox is a medical technology company that specializes in developing and producing neuroradiological and radiological products for the treatment of neurovascular diseases. Established in 2005 and headquartered in Bochum, Germany, the company offers a diverse portfolio of instruments designed for acute ischemic strokes and aneurysms. This includes innovative devices such as the pCR, a miniature instrument aimed at restoring blood flow in affected brain arteries, and the CRC, a mechanical thrombectomy system. Additionally, Phenox provides specialized implants for hemorrhagic strokes, including flow diverters and steerable guidewires. The company's products are distributed in Germany and internationally, focusing on improving patient safety and treatment outcomes through advanced technology.
TNI medical AG is a company specializing in the development, production, and marketing of diagnostic and therapeutic equipment for respiratory assistance therapy. The company's flagship product, the TNI SoftFlow System, is designed to provide comprehensive respiratory support while maximizing patient comfort. TNI medical distributes its products through its locations in Würzburg, Dessau, and Baltimore. Established in 2007, the company is headquartered in Würzburg, Germany, and has since positioned itself as a notable player in the respiratory care market. As of 2020, TNI medical operates as a subsidiary of Masimo Corporation.
numares AG, founded in 2004 and headquartered in Regensburg, Germany, specializes in the development and marketing of software-based test systems for clinical diagnostics and life science research. The company offers an in vitro diagnostic (IVD) system known as AXINON, which utilizes nuclear magnetic resonance (NMR) spectroscopy to analyze metabolomic networks. Through this technology, numares AG provides physicians with valuable insights into patients' disease status. The company employs magnetic group signaling (MGS) technology to enhance its NMR-based diagnostic solutions, focusing on areas such as cardiovascular diseases, nephrology, oncology, and neurology. As a prominent player in commercial NMR analytics in Europe, numares AG is recognized for delivering fast, cost-efficient, and reliable diagnostic services.
Biontis GmbH, founded in 2002 and based in Geesthacht, Germany, specializes in the development of automated processes for the biochemical analysis of complex liquid mixtures. The company produces laboratory equipment utilized in various applications, including water analysis, food inspection, forensic medicine, and clinical diagnostics. By automating treatment steps such as evaporation, heating, and dissolution, Biontis enables researchers to enhance their analytical capabilities, making them more innovative and cost-effective. The company primarily markets its products within Germany.
c-LEcta GmbH is a biotechnology company based in Leipzig, Germany, specializing in enzyme engineering and bioprocess development for regulated markets, including food and pharmaceuticals. Founded in 2004, the company focuses on creating application-oriented enzyme variants, which it either commercializes independently or develops in collaboration with industry partners. Among its notable products are DENARASE, a genetically engineered endonuclease designed for the removal of nucleic acids and viscosity reduction, and CalB Immo Plus, a hydrophobic immobilized CalB preparation. c-LEcta aims to provide customized enzymes and microbial strains through sustainable production processes, enabling clients to enhance their research and market capabilities.
Micropelt is a startup that emerged from a collaborative project between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Germany. The company specializes in developing thin film thermoelectric components through semiconductor manufacturing processes. Micropelt focuses on creating energy-harvesting systems that integrate micro-actuators and sensors. Its product offerings include thermoelectric cooling chips and thermoelectric generators designed for various applications, such as chip spot cooling, biomedical devices, heating, ventilation, and air conditioning systems, as well as fiber optics. These innovations aim to facilitate effective temperature management in individual rooms while contributing to CO2 reduction and enhancing user comfort. The company has secured funding from several financial institutions, enabling its growth and development within the thin-film technology sector.
CryLaS Crystal Laser Systems GmbH specializes in the design and manufacturing of diode-pumped solid-state lasers across the ultraviolet, visible, and infrared spectrum. Founded in 2004 and headquartered in Berlin, Germany, the company produces a range of lasers utilized in applications such as spectroscopy, environmental technology, analysis, and photolithography. Its product line includes both pulsed and continuous-wave lasers that leverage solid-state technology, catering to diverse fields like biotechnology, analytics, imaging, sensor systems, and micromachining. CryLaS distributes its products internationally through various partners, covering markets in Europe, North and South America, Asia, and beyond. The company's offerings are characterized by compact design, reliability, and cost-effectiveness, making them accessible for a wide range of scientific and industrial applications.